Abstract
Objectives
To explore performance measures among non-immigrants and immigrants attending BreastScreen Norway.
Methods
We analysed data from 2,951,375 screening examinations among non-immigrants and 153,026 among immigrants from 1996 to 2015. Immigrants were categorised into high- and low-incidence countries according to the incidence of breast cancer in their birth country. Performance measures, including attendance and recall rates, rates of screen-detected cancer (SDC) and interval breast cancer (IBC), positive predictive value (PPV) and histopathological tumour characteristics, were analysed. We used Fisher’s exact model and t tests for descriptive statistics, and Poisson regression, adjusting for age and screening history, comparing results for non-immigrants versus immigrants.
Results
Attendance rates were 78% for non-immigrants and 56% for immigrants (p < 0.001). Rates of prevalent screens were 24% for non-immigrants and 32% for immigrants (p < 0.001). Immigrants from low-incidence countries were younger at diagnosis than non-immigrants (57 years versus 60 years, p < 0.001). Recall rates were 3.1% for non-immigrants and 3.8% for immigrants (p < 0.001), while PPVs were 17% and 14% (p < 0.001), respectively. IBCs in immigrants from low-incidence countries were more often triple negative (RRadj 1.81, 95% CI 1.11–2.94) than those in non-immigrants. Both SDC and IBC in immigrants from low-incidence countries tended more often to be histological grade 3 than those in non-immigrants.
Conclusion
Immigrants had lower attendance rates, higher recall rates and lower PPV than non-immigrants. The optimal age range and screening interval for immigrant women from low-incidence countries need to be further investigated.
Key Points
• Immigrants from countries with a low incidence of breast cancer had their breast cancer diagnosed at a younger age than non-immigrants.
• Interval breast cancers detected in immigrants from countries with a low incidence of breast cancers were more often triple negative than those in non-immigrants.
• The optimal age range and screening interval for immigrant women from low-incidence countries and non-immigrants might differ.
Similar content being viewed by others
Abbreviations
- DCIS:
-
Ductal carcinoma in situ
- ER:
-
Oestrogen receptor
- FFDM:
-
Full-field digital mammography
- IBC:
-
Interval breast cancer
- ICNST:
-
Invasive carcinoma of no special type
- IHC:
-
Immunohistochemistry
- ILC:
-
Invasive lobular carcinoma
- PR:
-
Progesterone receptor
- SDC:
-
Screen-detected cancer
- SFM:
-
Screen-film mammography
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. https://doi.org/10.3322/caac.21492
Hjerkind KV, Qureshi SA, Møller B et al (2017) Ethnic differences in the incidence of cancer in Norway. Int J Cancer 140:1770–1780
Thogersen H, Møller B, Robsahm TE, Aaserud S, Babigumira R, Larsen IK (2017) Comparison of cancer stage distribution in the immigrant and host populations of Norway, 1990-2014. Int J Cancer 141:52–61
Preat F, Simon P, Noel JC (2014) Differences in breast carcinoma immunohistochemical subtypes between immigrant Arab and European women. Diagn Pathol 9:26
Newman LA (2017) Breast cancer disparities: socioeconomic factors versus biology. Ann Surg Oncol 24:2869–2875
Lauby-Secretan B, Scoccianti C, Loomis D et al (2015) Breast-cancer screening—viewpoint of the IARC Working Group. N Engl J Med 372:2353–2358
International Agency for Research on Cancer (2002) IARC handbooks of cancer prevention. Volume 7. Breast cancer screening. IARC. Lyon, France
Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L (2008) European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition—summary document. Ann Oncol 19:614–622
European Commission Initiative on Breast Cancer (2016) Recommendations on breast cancer screening. Available via http://ecibc.jrc.ec.europa.eu/recommendations/details/3. Accessed 9 Apr 2018
Bhargava S, Moen K, Qureshi SA, Hofvind S (2018) Mammographic screening attendance among immigrant and minority women: a systematic review and meta-analysis. Acta Radiol. https://doi.org/10.1177/0284185118758132
Hofvind S (Ed.) (2017) Cancer in Norway 2016. Special issue: the Norwegian Breast Cancer Screening Program, 1996-2016: celebrating 20 years of organised mammographic screening. Cancer Registry of Norway, Oslo
Bhargava S, Tsuruda K, Moen K, Bukholm I, Hofvind S (2017) Lower attendance rates in immigrant versus non-immigrant women in the Norwegian Breast Cancer Screening Programme. J Med Screen. https://doi.org/10.1177/0969141317733771
Statistics Norway (2016) Fakta om innvandring. Available via https://www.ssb.no/innvandring-og-innvandrere/faktaside/innvandring. Accessed 9 Apr 2018
Cancer Registry of Norway (2015) Breast Cancer Screening Programme—results from process indicators, 2006-2013/14. Cancer Registry of Norway, Oslo
Cancer Registry of Norway (2017) Informasjonsmateriell. Cancer Registry of Norway, Oslo. Available via https://www.kreftregisteret.no/screening/Mammografiprogrammet/informasjonsmateriell/. Accessed 23 July 2018
Ministry of Health and Care Services (2001) Forskrift om innsamling og behandling av helseopplysninger i Kreftregisteret (Kreftregisterforskriften). Ministry of Health and Care Services, Oslo. Available via https://lovdata.no/dokument/SF/forskrift/2001-12-21-1477. Accessed 9 Apr 2018
Ministry of Health and Care Services (2014) Lov om helseregistre og behandling av helseopplysninger (Helseregisterloven). Ministry of Health and Care Services, Oslo. Available via https://lovdata.no/dokument/NL/lov/2014-06-20-43. Accessed 9 Apr 2018
Larsen IK, Småstuen M, Johannesen TB et al (2009) Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 45:1218–1231
Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403
Peto J (2001) Cancer epidemiology in the last century and the next decade. Nature 411:390–395
Goldhirsch A, Winer EP, Coates AS et al (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013. Ann Oncol 24:2206–2223
Plasilova ML, Hayse B, Killelea BK, Horowitz NR, Chagpar AB, Lannin DR (2016) Features of triple-negative breast cancer: analysis of 38,813 cases from the national cancer database. Medicine (Baltimore) 95:e4614
Fallahpour S, Navaneelan T, De P, Borgo A (2017) Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data. CMAJ Open 5:E734–E739
Mousavi SM, Hemminki K (2015) Cancer incidence, trends, and survival among immigrants to Sweden: a population-based study. Eur J Cancer Prev 24(Suppl 1):S1–S63
Stapleton SM, Oseni TO, Bababekov YJ, Hung YC, Chang DC (2018) Race/ethnicity and age distribution of breast cancer diagnosis in the United States. JAMA Surg. https://doi.org/10.1001/jamasurg.2018.0035
Moshina N, Roman M, Sebuødegård S, Waade GG, Ursin G, Hofvind S (2018) Comparison of subjective and fully automated methods for measuring mammographic density. Acta Radiol 59:154–160
Acknowledgements
We would like to thank the Norwegian Breast Cancer Society and the Norwegian ExtraFoundation for Health and Rehabilitation for their support. We would also like to thank Kaitlyn Tsuruda for the language editing.
Funding
This study was supported by a grant from the Norwegian Breast Cancer Society and received funding from the Norwegian ExtraFoundation for Health and Rehabilitation (2016/FO76429) (https://www.extrastiftelsen.no/logo/; English description towards the end).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Solveig Hofvind.
Conflict of interest
The authors declare that they have no conflict of interest.
Statistics and biometry
One of the authors has significant statistical expertise.
Informed consent
Written informed consent was waived by the institutional review board (the Regional Ethical Committee approved the use of the data for the study).
Ethical approval
Institutional review board approval was obtained. This study has been approved by the Regional Committee for Medical and Health Research Ethics in South-eastern Norway, REC South East (2013/795).
Study subjects or cohorts overlap
This cohort is used in several studies from the Cancer Registry of Norway. However, this paper represents an original study which has not been performed previously.
Methodology
• prospective
• Cohort study (historic cohort)
• Performed at one institution
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 43 kb)
Rights and permissions
About this article
Cite this article
Bhargava, S., Akslen, L.A., Bukholm, I.R.K. et al. Performance measures among non-immigrants and immigrants attending BreastScreen Norway: a population-based screening programme. Eur Radiol 29, 4833–4842 (2019). https://doi.org/10.1007/s00330-019-6009-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-019-6009-2